Apoptosis Inducers

Artocarpin is a potent apoptosis inducer that targets various signaling molecules, including NF-κB, Erk1/2, p38 MAPK, and Akt kinases. It stimulates the production of reactive oxygen species (ROS) and activates both p53-dependent and independent apoptotic pathways, resulting in G1-phase cell cycle arrest and autophagic cell death. Artocarpin displays significant cytotoxic and bactericidal effects against cancer cells, reduces bacterial burden, and possesses anti-inflammatory, analgesic, and anti-angiogenic properties, making it valuable for cancer and inflammatory research applications.

Kuanoniamine A is a pyridoacridine alkaloid that functions as an apoptosis inducer. Its primary mechanism involves the inhibition of DNA synthesis and regulation of the cell cycle, effectively decreasing the number of cells in the G2/M phase. Kuanoniamine A demonstrates significant anti-proliferative effects on human lymphocytes and is utilized in research focused on breast cancer, glioma, non-small cell lung cancer, and melanoma.

EV206 is a selective binder to the N-terminal domain of Hsp70, functioning as an apoptosis inducer. It promotes the degradation of Hsp70 through the ubiquitin-proteasome pathway, leading to reduced protein stability and inhibition of cellular growth. EV206 effectively induces apoptotic cell death in non-small cell lung cancer cells, suppresses colony formation, and downregulates markers associated with cancer stem cells. Additionally, it demonstrates anti-tumor activity in H460 xenograft models. This compound serves as a valuable tool for research in non-small cell lung cancer.

Lumichrome is a photodegradation product of riboflavin that acts as an apoptosis inducer. It has been shown to inhibit the growth of human lung cancer cells and induce apoptosis through a p53-dependent mechanism. Additionally, Lumichrome serves as an inhibitor of the AKT/β-catenin signaling pathway, highlighting its potential utility in cancer research and therapeutic studies.

Karanjin is a furanoflavonoid with a primary mechanism as an apoptosis inducer. It demonstrates significant anti-cancer, anti-inflammatory, anti-diabetic, and antioxidant activities, making it a valuable compound for various research applications. Additionally, Karanjin exhibits protective effects against ulcerative conditions and Alzheimer’s disease, as well as insect repellent and acaricidal properties. Its diverse biological activities make it a promising candidate for studies in cancer therapy, inflammation, and neuroprotection.

4′-O-Methylglabridin is an apoptosis inducer that disrupts the cell cycle and exhibits antioxidant and cytotoxic activities against cancer cells. It has been shown to inhibit a range of cancer cell lines, including liver, breast, and colorectal cancers, by reducing phosphorylated Rb and p21 protein levels, leading to an accumulation of cells in the subG1 and G2/M phases. Furthermore, 4′-O-Methylglabridin triggers caspase-dependent apoptosis through the release of cytochrome C and activation of caspase-9. Its antioxidant properties also include the inhibition of lipid peroxidation and prevention of LDL oxidation. This compound is valuable for research in cancer biology and atherosclerosis.